Literature DB >> 27643445

Managing Incidental Lung Nodules in Patients With a History of Oncologic Disease: A Survey of Thoracic Radiologists.

Mariaelena Occhipinti1, Benedikt H Heidinger, Christina Pfannenberg, Reginald F Munden, Ronald L Eisenberg, Alexander A Bankier.   

Abstract

PURPOSE: The aim of this study was to analyze the impact that a clinical history of an oncologic disease may have on the management decisions for incidentally detected lung nodules on chest computed tomographic (CT) examinations.
MATERIALS AND METHODS: An electronic survey was sent to all 796 members of the Society of Thoracic Radiology regarding criteria for the management of incidentally detected lung nodules in oncologic patients, as well as recommendations for nodule follow-up. Nodule characteristics and clinical parameters used by respondents were analyzed. Differences between variables were examined using the χ test.
RESULTS: Of the 796 Society of Thoracic Radiology members, 178 (22.36%) replied. Most respondents were subspecialized in cardiothoracic imaging (92.70%) and practiced in an "academic or teaching hospital setting" (75.28%) with a "dedicated oncology center" (94.03%). "History of oncologic disease" was the most important factor (98.87%) for management decisions. In patients with such a history, respondents most commonly used "experience and common sense" (56.74%) and reported "all incidentally found lung nodules" (65.73%, P<0.0001). "Size" and "shape" were the 2 most important nodule characteristics (33.61% and 27.05%, respectively) used to consider a nodule "clinically relevant," and "size" (44.07%) was also the most important nodule characteristic prompting recommendation for short-term CT follow-up. Follow-up CT examinations in oncologic patients were recommended by 75.84% of respondents.
CONCLUSIONS: In patients with a history of oncologic disease, radiologists tend to report every detected nodule and to routinely recommend follow-up CT examinations. Although most radiologists rely on "experience and common sense" in managing these nodules, greater standardization of lung nodule management in oncologic patients is needed, ideally through guidelines tailored to this patient population.

Entities:  

Mesh:

Year:  2017        PMID: 27643445     DOI: 10.1097/RTI.0000000000000231

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  5 in total

Review 1.  Management of incidental lung nodules <8 mm in diameter.

Authors:  Marcelo Sánchez; Mariana Benegas; Ivan Vollmer
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  The natural course of incidentally detected, small, subsolid lung nodules-is follow-up needed beyond current guideline recommendations?

Authors:  Benedikt H Heidinger; Mario Silva; Constance de Margerie-Mellon; Paul A VanderLaan; Alexander A Bankier
Journal:  Transl Lung Cancer Res       Date:  2019-12

3.  Impact of Bayesian penalized likelihood reconstruction on quantitative and qualitative aspects for pulmonary nodule detection in digital 2-[18F]FDG-PET/CT.

Authors:  Niklas Lohaus; Florian Enderlin; Stephan Skawran; Alexander Maurer; Ahmad M A Abukwaik; Daniel Franzen; Martin W Huellner; Michael Messerli
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

4.  Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.

Authors:  Moritz Schwyzer; Katharina Martini; Dominik C Benz; Irene A Burger; Daniela A Ferraro; Ken Kudura; Valerie Treyer; Gustav K von Schulthess; Philipp A Kaufmann; Martin W Huellner; Michael Messerli
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

5.  The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT.

Authors:  Magdy Soliman; Teresa Petrella; Pascal Tyrrell; Frances Wright; Nicole J Look Hong; Hua Lu; Petros Zezos; Laura Jimenez-Juan; Anastasia Oikonomou
Journal:  Eur J Radiol Open       Date:  2019-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.